Olema Oncology
Developing therapies that offer the potential to improve outcomes for women living with cancer.
loading funding rounds…
Vivo Capital(exited)
Avoro Capital Advisors(exited)
BlackRock(exited)
Deerfield(exited)
OrbiMed(exited)
BVF Partners(exited)
Logos Capital(exited)
Janus Henderson Investors(exited)
Cormorant Asset Management(exited)
Wellington Management(exited)
RA Capital Management(exited)
Venrock(exited)
Citadel(exited)
Foresite Capital(exited)
| USD | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.